EMERALD ADVISERS, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001015083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q3 2024 · 248 positions · Total reported value $2.59B · Top-10 concentration 21.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.0% · 14 new · 86 cut · 28 exited

Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, EMERALD ADVISERS, LLC disclosed 248 equity positions with a combined reported value of $2.59B. The filing implies a diversified portfolio: its ten largest positions account for 21.2% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q3 2024 were FTAI ($83.59M), FRPT ($70.30M), CRS ($59.05M). By sector, the heaviest allocations are Technology 20.6%, Health Care 19.1%. Versus the prior quarter, allocation shifted toward Financials (+2.6pp), Communication Services (+1.7pp) and away from Industrials (-0.9pp), Consumer Discretionary (-1.4pp).

Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 84% of names.

The largest new positions opened in Q3 2024 were CDMO ($16.49M), TTMI ($13.69M), UMBF ($12.87M).

Of the 28 positions fully exited versus the prior quarter, the largest were SVV ($9.16M), CHUY ($9.00M), MAX ($7.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • CDMO AVID BIOSERVICES INC · $16.49M
  • TTMI TTM TECHNOLOGIES INC · $13.69M
  • UMBF UMB FINL CORP · $12.87M
  • SIGI SELECTIVE INS GROUP INC · $11.77M
  • CVLT COMMVAULT SYS INC · $10.70M
  • CWAN CLEARWATER ANALYTICS HOLDINGS INC A · $10.15M
  • KROS KEROS THERAPEUTICS INC · $9.03M
  • SYRE SPYRE THERAPEUTICS INC · $8.60M

Fully Exited (vs previous quarter)

  • SVV SAVERS VALUE VLG INC · prev qtr: $9.16M
  • CHUY CHUYS HLDGS INC · prev qtr: $9.00M
  • MAX MEDIAALPHA INC · prev qtr: $7.88M
  • ARCB ARCBEST CORP · prev qtr: $6.81M
  • HAE HAEMONETICS CORP MASS · prev qtr: $5.47M
  • PRFT PERFICIENT INC · prev qtr: $4.05M
  • CRWD CROWDSTRIKE HOLDINGS INC · prev qtr: $2.03M
  • ICLR ICON PUB LTD CO · prev qtr: $547.32K

Insider Transactions (Form 4)

Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: LEOLA, PA, United States
  • SEC registration: 801-40263 (status: Approved), registered 1991-11-25
  • Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Website: teamemerald.com

Portfolio Structure

  • 237 positions · $4.25B reported value (Q2 2026)
  • Top 10 holdings = 17.4% of reported value
  • Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
  • Average position size: $17.93M

Sector Tilt

  • Information Technology 26.5%
  • Health Care 21.7%
  • Consumer Discretionary 19.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
  • 52 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 20.6%
Health Care 19.1%
Industrials 13.7%
Financials 12.5%
Other 15.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 628.93K $83.59M 3.23%
3.23%
Reduce
2 514.00K $70.30M 2.72%
2.72%
Reduce
3 370.01K $59.05M 2.28%
2.28%
Reduce
4 933.66K $52.75M 2.04%
2.04%
Reduce
5 689.81K $50.36M 1.95%
1.95%
Add
6 620.88K $49.53M 1.92%
1.92%
Add
7 1.59M $49.07M 1.90%
1.90%
Add
8 669.25K $46.44M 1.80%
1.80%
Add
9 884.30K $44.04M 1.70%
1.70%
Add
10 217.67K $43.64M 1.69%
1.69%
Add
11 637.47K $42.65M 1.65%
1.65%
Hold
12 449.97K $42.60M 1.65%
1.65%
Add
13 1.74M $40.57M 1.57%
1.57%
Reduce
14 182.48K $39.51M 1.53%
1.53%
Add
15 695.50K $36.54M 1.41%
1.41%
Add
16 874.58K $35.62M 1.38%
1.38%
Add
17 398.81K $35.33M 1.37%
1.37%
Add
18 264.35K $35.10M 1.36%
1.36%
Add
19 375.87K $34.77M 1.34%
1.34%
Add
20 317.24K $34.09M 1.32%
1.32%
Add
21 828.20K $33.56M 1.30%
1.30%
Add
22 441.30K $32.29M 1.25%
1.25%
Add
23 491.41K $32.12M 1.24%
1.24%
Add
24 827.30K $31.97M 1.24%
1.24%
Add
25 505.54K $31.79M 1.23%
1.23%
Add
26 569.80K $31.65M 1.22%
1.22%
Add
27 252.66K $31.37M 1.21%
1.21%
Add
28 315.18K $31.15M 1.20%
1.20%
Reduce
29 440.33K $30.17M 1.17%
1.17%
Add
30 895.25K $28.36M 1.10%
1.10%
Add
31 1.10M $28.10M 1.09%
1.09%
Add
32 604.72K $27.82M 1.08%
1.08%
Add
33 1.96M $27.43M 1.06%
1.06%
Add
34 280.67K $26.24M 1.01%
1.01%
Add
35 239.46K $26.09M 1.01%
1.01%
Hold
36 180.99K $25.63M 0.99%
0.99%
Add
37 257.30K $25.01M 0.97%
0.97%
Add
38 1.68M $24.81M 0.96%
0.96%
Reduce
39 706.44K $24.77M 0.96%
0.96%
Add
40 252.82K $24.52M 0.95%
0.95%
Add
41 378.54K $23.99M 0.93%
0.93%
Add
42 852.44K $23.87M 0.92%
0.92%
Add
43 1.31M $23.71M 0.92%
0.92%
Add
44 561.41K $23.70M 0.92%
0.92%
Add
45 150.91K $23.69M 0.92%
0.92%
Reduce
46 2.88M $23.63M 0.91%
0.91%
Add
47 1.18M $23.48M 0.91%
0.91%
Add
48 683.64K $22.79M 0.88%
0.88%
Add
49 93.17K $22.03M 0.85%
0.85%
Add
50 611.51K $21.65M 0.84%
0.84%
Add

FAQ

What did EMERALD ADVISERS, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, EMERALD ADVISERS, LLC reported 248 equity positions worth $2.59B in aggregate; its largest disclosed positions were FTAI ($83.59M), FRPT ($70.30M), CRS ($59.05M).

How large is EMERALD ADVISERS, LLC's portfolio?

EMERALD ADVISERS, LLC reported $2.59B of long equity holdings across 248 positions as of 2024-Q3. Top-10 holdings account for 21.2% of reported value.

What is EMERALD ADVISERS, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →